Volume-based growth tumor kinetics as a prognostic biomarker for patients with EGFR mutant lung adenocarcinoma undergoing EGFR tyrosine kinase inhibitor therapy: a case control study

BACKGROUND: We aim to determine whether volumetric assessment has the potential to serve as a prognostic biomarker, and to assess the relationship between longitudinal tumor data during treatment and prognosis in lung adenocarcinoma patients with sensitizing EGFR mutations treated with EGFR tyrosine...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji Hyun, Lee, Ho Yun, Ahn, Myung-Ju, Park, Keunchil, Ahn, Jin Seok, Sun, Jong-Mu, Lee, Kyung Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794857/
https://www.ncbi.nlm.nih.gov/pubmed/26984681
http://dx.doi.org/10.1186/s40644-016-0063-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794857/
https://www.ncbi.nlm.nih.gov/pubmed/26984681
http://dx.doi.org/10.1186/s40644-016-0063-7

Ejemplares similares